Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCT1080220524
Open-label, single-arm trial of pravastatin in hypercholesterolemia and atherosclerotic disease, sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Occlusive atherosclerotic complications.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCT1080220524.